Acadia Pharmaceuticals

Director, Quality Assurance

Parsippany-Troy Hills, New Jersey, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalsIndustries

Requirements

Candidates must possess a minimum Bachelor's degree in Life Sciences, Engineering, or a related field, with over 10 years of experience in pharmaceutical manufacturing, including at least 5 years in senior QA leadership. A strong understanding of GxP, FDA regulations, and industry standards is essential, along with proven expertise in managing quality systems, leading audits, and ensuring regulatory compliance. Excellent leadership, communication, risk management, and CAPA process skills are required, and while not mandatory, a Certified Lead Auditor qualification and familiarity with quality systems like Veeva and LIMS are preferred.

Responsibilities

The Director, Quality Assurance will lead and mentor the QA team, develop strategic quality plans, and serve as a key member of the site leadership team. Responsibilities include ensuring adherence to GxP standards, managing regulatory inspections, overseeing batch record reviews and product release, and managing the quality system (deviations, complaints, recalls, change control, validation). The role involves driving continuous improvement, overseeing QA training, collaborating with other departments, leading internal and external audits, managing the QA department budget, and providing leadership on quality and regulatory issues.

Skills

Quality Assurance
Regulatory Compliance
GxP
Leadership
Mentoring
Strategic Planning
Risk Mitigation
Product Quality
Patient Safety
Team Management

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI